MDLZ
28
2
FCX
44
4
AON
25
4
PCG
59
9
BDX
59
3
ROST
60
3
HP
44
14
TMO
52
8
L
54
5
ADI
54
4
IP
53
3
MAR
57
3
NKE
36
2
AMP
43
2
BK
60
2
LEG
16
2
WMT
68
-2
GM
55
6
LEN
21
3
DHI
36
3
MDLZ
28
2
FCX
44
4
AON
25
4
PCG
59
9
BDX
59
3
ROST
60
3
HP
44
14
TMO
52
8
L
54
5
ADI
54
4
IP
53
3
MAR
57
3
NKE
36
2
AMP
43
2
BK
60
2
LEG
16
2
WMT
68
-2
GM
55
6
LEN
21
3
DHI
36
3
Financhill
Back

Nuvve Holding 10K Form

Sell
14

NVVE
Nuvve Holding

Last Price:
$3.04
Seasonality Move:
-40.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVVE News And Ratings

See the #1 stock for the next 7 days that we like better than NVVE

NVVE Financial Statistics

Sales & Book Value

Annual Sales: $8M
Cash Flow: $-3.5M
Price / Cash Flow: 0
Annual Sales: $3.43
Price / Book: 0.84

Profitability

EPS (TTM): -95.87000
Net Income (TTM): $-19.6M
Gross Margin: $1M
Return on Equity: -330.26%
Return on Assets: -84.56%

Nuvve Holding Earnings Forecast

Key Nuvve Holding Financial Ratios

  • The Gross Profit Margin over the past 4 years for NVVE is 12.79%.
  • The Selling, General & Administrative Expenses for NVVE have been equal to 308.48% of Gross Profit Margin.
  • The Research & Development expenses have been 109.44% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of NVVE is -390.79% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Nuvve Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electrical Equipment
Sector: Industrials
Current Symbol: NVVE
Website: nuvve.com

Debt

Debt-to-Equity Ratio: 0.83
Current Ratio: 1.15
Quick Ratio: 0.22

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NVVE Technical Analysis vs Fundamental Analysis

Sell
14
Nuvve Holding (NVVE) is a Sell

Is Nuvve Holding a Buy or a Sell?

  • Nuvve Holding stock is rated a Sell
    The current Nuvve Holding [NVVE] share price is $2.87. The Score for NVVE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.